{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/menorrhagia/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"fc278e0b-a1a4-54d5-b44c-ddde104596ea","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 340d95a6-0ec6-43a9-8c69-26ed42b60670 --><h2>How should I assess a woman with suspected menorrhagia?</h2><!-- end field 340d95a6-0ec6-43a9-8c69-26ed42b60670 -->","summary":"","htmlStringContent":"<!-- begin item 6acedfe7-81e7-4167-b564-4b7d9d2fbfc2 --><!-- begin field 36da447a-bd6e-4a11-846d-12609b23259a --><ul><li><strong>Take a detailed clinical history.</strong><ul><li>Ask about: <ul><li>The nature of the bleeding and the impact on the woman's quality of life.</li><li>The woman's age — in the first year after menarche and in the perimenopause, heavy bleeding is associated with irregular cycles which may be due to anovulatory bleeding.</li><li>Cervical screening history — to confirm she has attended as scheduled and results were normal. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cervical-screening/\">Cervical screening</a>.</li><li>Details of the woman's normal menstrual cycle (such as length of the cycle and number of days of menstruation) and any variation of this pattern. </li><li>Sexual history —<strong> </strong>this should include current contraceptive use (hormonal contraceptives may cause irregular bleeding), contraceptive plans, and future plans for a family (as this may impact on the choice of treatment). Consider the possibility of pregnancy, including an ectopic pregnancy, in all women with menorrhagia. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/ectopic-pregnancy/\">Ectopic pregnancy</a>.</li><li>Medical history — ask about endometriosis, a family history of coagulation disorders that may have a hereditary component (for example von Willebrand disease), and other comorbidities.</li><li>Drug history (including previous treatment for menorrhagia).</li><li>Related symptoms (such as persistent intermenstrual bleeding, pelvic pain, and/or pressure symptoms) — these may suggest uterine cavity abnormality, histological abnormality, adenomyosis, or fibroids.</li></ul></li><li><strong>If the woman has a history of menorrhagia <em>without </em>other related symptoms (such as persistent intermenstrual bleeding, pelvic pain, and/or pressure symptoms),</strong> consider starting <a class=\"topic-reference internal-reference\" href=\"/topics/menorrhagia/management/management/#primary-care-management\">pharmacological treatment</a> <em>without</em> carrying out a physical examination (unless the treatment chosen is the levonorgestrel-releasing intrauterine system [LNG IUS]).</li></ul></li><li><strong>If the woman has a history of menorrhagia with other related symptoms, offer a physical examination.</strong><ul><li>Look for features of an underlying systemic disease, for example:<ul><li>Hypothyroidism — goitre. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a>.</li><li>Coagulation disorders (for example von Willebrand disease) — bruises or petechiae. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/bruising/\">Bruising</a>.</li><li>Polycystic ovary syndrome — acne, hirsutism. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/polycystic-ovary-syndrome/\">Polycystic ovary syndrome</a>.</li></ul></li><li>Perform an abdominal examination — to assess for large fibroids and other masses. </li><li>Perform a bimanual pelvic examination (including a speculum examination of the cervix), except in young girls who are not sexually active:<ul><li>To exclude an underlying cause, such as ascites, fibroids, or gynaecological cancer. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/fibroids/\">Fibroids</a>, <a class=\"topic-reference external-reference\" href=\"/topics/cervical-cancer-hpv/\">Cervical cancer and HPV</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/\">Gynaecological cancers - recognition and referral</a>.</li><li>If the LNG-IUS is being considered. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-ius-iud/\">Contraception - IUS/IUD</a>.</li></ul></li></ul></li><li><strong>Arrange investigations as appropriate.</strong><ul><li>Arrange a full blood count in all women — to rule out iron deficiency anaemia (which is a strong indicator of excessive menstrual bleeding). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a>.</li><li>For women with suspected submucosal fibroids, polyps, or endometrial pathology — offer a hysteroscopy or ultrasound to assess for a cause of menorrhagia. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/menorrhagia/diagnosis/investigations-for-the-cause-of-menorrhagia/\">Investigations for the cause of menorrhagia</a>.<ul><li><strong>If</strong> <strong>the woman's history and/or examination suggests a low risk of fibroids, uterine cavity abnormality, histological abnormality, or adenomyosis, </strong>consider starting <a class=\"topic-reference internal-reference\" href=\"/topics/menorrhagia/management/management/#primary-care-management\">pharmacological treatment</a> for menorrhagia without investigating the cause.</li></ul></li><li>Arrange other investigations as suggested by history and clinical findings, for example:<ul><li>A vaginal or cervical swab — if an infection is suspected.</li><li>Thyroid function tests — if there are features of hypothyroidism. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a>.</li><li>Tests for coagulation disorders (for example von Willebrand disease) — in women who have had heavy menstrual bleeding since menarche, and a personal or a family history of a coagulation disorder. </li></ul></li><li><strong>It is <em>not</em> necessary to measure blood loss to diagnose menorrhagia.</strong></li></ul></li></ul><!-- end field 36da447a-bd6e-4a11-846d-12609b23259a --><!-- end item 6acedfe7-81e7-4167-b564-4b7d9d2fbfc2 -->","topic":{"id":"d4abfe41-b89f-5d51-8168-7ff98b4290f9","topicId":"4013d716-0ba5-4984-bfb1-8c7eca832ba8","topicName":"Menorrhagia","slug":"menorrhagia","lastRevised":"Last revised in December 2018","chapters":[{"id":"0e4b035a-9880-5848-b317-d92515f750d7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"98c45e96-1179-53a4-9b74-a5f71fffaebd","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"73a36e11-2419-5f1f-9d0a-989641466fbf","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"49315340-c2d5-5025-a18d-ab2347baae5b","slug":"changes","fullItemName":"Changes"},{"id":"a232dfd0-a500-5e6b-9ead-3c3c94f0d2cf","slug":"update","fullItemName":"Update"}]},{"id":"cdc50c06-ff06-509a-be3e-1047ea50bc07","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e5043cba-12e2-5f47-aac7-4e74d516a7fa","slug":"goals","fullItemName":"Goals"},{"id":"b1ea37fe-6d24-5529-9f7e-c0e49ccba796","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cf03761e-6677-5ba5-ac47-f290b7cb66ec","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"24f740a2-df74-5305-b364-52d1fa68040a","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"913b3856-8846-53a2-86c7-f489c766e0f4","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"45c06974-d676-5c1e-bc8f-269a8c65df4f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7d698fba-d82e-55be-bcc0-0ee11398e628","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"aa066829-e43c-5a83-b602-2680d838463a","slug":"definition","fullItemName":"Definition"},{"id":"37436c25-6db1-5e7c-b8fd-7590cd5ca25d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e5c102c5-46d5-5096-bb8b-d2ef0960e353","slug":"causes","fullItemName":"Causes"},{"id":"b7f926cd-7de3-5b25-9697-78920cccf7b7","slug":"complications","fullItemName":"Complications"}]},{"id":"305d1c2b-5b47-5eda-adc5-03782afe2229","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"fc278e0b-a1a4-54d5-b44c-ddde104596ea","slug":"assessment","fullItemName":"Assessment"},{"id":"1d41d3f0-3049-510f-982a-9d9c39c5d52f","slug":"investigations-for-the-cause-of-menorrhagia","fullItemName":"Investigations for the cause of menorrhagia"}]},{"id":"5c051ed4-4e95-59b7-8bf1-c9e426198f5f","fullItemName":"Management","slug":"management","subChapters":[{"id":"e30d2783-35fc-5470-9fb3-b8a643f83450","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"324cd8d0-2857-5c2b-bd8e-ac2d83c5b55d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c6b368dc-8409-55ee-8072-ffa3dc54a6f0","slug":"tranexamic-acid","fullItemName":"Tranexamic acid"},{"id":"13dd98d9-6054-5177-8564-df8c7ede9e5c","slug":"nonsteroidal-anti-inflammatory-drugs","fullItemName":"Nonsteroidal anti-inflammatory drugs"},{"id":"0e5ebc73-f73e-5d12-9e9a-82f8373fc507","slug":"oral-norethisterone","fullItemName":"Oral norethisterone"}]},{"id":"5964d183-6ca2-5e15-9a46-bd0c666e6146","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"443b20d0-895a-5b92-810b-17af26ab31e6","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"93531fdf-665e-5277-9d61-5b62984a866f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"949f5d38-0e7a-59b8-a641-b1096ac7f3b3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dd5aaa9a-b897-51a6-b133-d7e4170711df","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"81610614-c77a-5340-b5b3-721aafb19cc3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"83d1c27f-0003-5757-b8a1-90f777106d61","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"8fe218e8-4e7d-55af-9b5b-4f2bad344402","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"305d1c2b-5b47-5eda-adc5-03782afe2229","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"db040e6f-d060-50ab-b5e1-39bbf341ac35","slug":"basis-for-recommendation-36c","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 57bccf94-3ed5-4cd6-948c-a73e01073768 --><h3>Basis for recommendation</h3><!-- end field 57bccf94-3ed5-4cd6-948c-a73e01073768 -->","summary":null,"htmlStringContent":"<!-- begin item 36c1dd8a-d42a-4c88-b27d-a73e010737ad --><!-- begin field 14d53bca-f890-4a03-b5e3-a73e01073768 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guideline <em>Heavy menstrual bleeding: assessment and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menorrhagia/references/\">NICE, 2018</a>]<em>,</em> the Faculty of Sexual and Reproductive Healthcare (FSRH) guidance <em>Problematic bleeding with hormonal contraception </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/menorrhagia/references/\">FSRH, 2015</a>], the Institute of Obstetricians and Gynaecologists (IOG) guideline <em>The Investigation and management of menorrhagia </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/menorrhagia/references/\">IOG, 2015</a>], and the British Medical Journal (BMJ) best practice guides <em>Menorrhagia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menorrhagia/references/\">BMJ, 2017a</a>] and <em>Dysfunctional uterine bleeding</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menorrhagia/references/\">BMJ, 2017b</a>]. </p><ul><li>The recommendations on when pharmacological treatments can be considered without carrying out physical examination or investigations for the cause of menorrhagia are based on the NICE guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menorrhagia/references/\">NICE, 2018</a>]. For full details of the evidence for the recommendations and the NICE guideline committee's discussions, see the <a data-hyperlink-id=\"2922cd99-bbe9-4801-af9a-a9ad00d78b71\" href=\"http://www.nice.org.uk/Guidance/NG88/evidence\">NICE evidence reviews</a>.</li></ul><!-- end field 14d53bca-f890-4a03-b5e3-a73e01073768 --><!-- end item 36c1dd8a-d42a-4c88-b27d-a73e010737ad -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}